Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Samer Ghazi"'
Autor:
Gillian Parker, Sarah Hunter, Samer Ghazi, Robin Z Hayeems, Francois Rousseau, Fiona A Miller
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0280582 (2023)
BackgroundDecision impact studies have become increasingly prevalent in cancer prognostic research in recent years. These studies aim to evaluate the impact of a genomic test on decision-making and appear to be a new form of evidence of clinical util
Externí odkaz:
https://doaj.org/article/cd4cf6ed78ea498d8abd4d7fc4f771f2
Autor:
Samer Ghazi
Publikováno v:
Bone Marrow Transplantation. 55:726-755
Autor:
Mohsen Alzahrani, Ayman Alhejazi, Bader Alahmari, Samer Ghazi, Mohammad Snnallah, Moussab Damlaj, Ahmed Alaskar
Publikováno v:
World Journal of Transplantation. 8:252-261
Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma
Autor:
Mohsen Alzahrani, Samer Ghazi, Ayman Hejazi, Abdulrahman Alsultan, Giamal Gmati, Khadega A. Abuelgasim, Hind Salama, Rodaina Abujoub, Mohammed Sh. Essa, Heba Alshobaki, Enas Basher, Husam Mazin Alsadi, Mazin Ahmed, Bader Alahmari, Moussab Damlaj, Ahmed Alaskar
Publikováno v:
Bone marrow transplantation. 57(2)
Autor:
Moussab Damlaj, Bader Alahmari, Sameera M. Al Johani, Mohammad Bosaeed, Ahmed Alaskar, Farhan Khalid, Mohsen Alzahrani, Ayman Alhejazi, Samer Ghazi, Abdulrahman Alsaedy
Publikováno v:
Current research in translational medicine. 68(3)
Preemptive therapy (PET) for cytomegalovirus (CMV) reactivation post allogeneic hematopoietic stem cell transplantation (SCT) was shown to decrease the incidence of CMV disease. However, the optimal PET threshold is elusive.To examine the efficacy of
Autor:
A. Alaskar, Moussab Damlaj, Mohsen Alzahrani, G.M. Gmati, Ayman Alhejazi, Bader Alahmari, Samer Ghazi, Khadega A. Abuelgasim
Publikováno v:
Hematological Oncology. 37:492-494
Publikováno v:
Bone Marrow Transplantation. 53:1366-1368
Autor:
Moussab Damlaj, Samer Ghazi, A Al Askar, Osama Ali, Giamal Gmati, Ayman Hejazi, Ghulam Syed, Mohsen Alzahrani, Khadega A. Abuelgasim, Tabrez Pasha, Hind Salama
Publikováno v:
Bone Marrow Transplantation. 52:1342-1344
High-dose salvage chemotherapy followed by haematopoietic stem cell transplantation (HCT) is the standard of care in transplant eligible relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL).1 Approximately, half of patients receiving HCT will a
Autor:
Moussab, Damlaj, Mohammad, Snnallah, Ayman, Alhejazi, Samer, Ghazi, Bader, Alahmari, Ahmed, Alaskar, Mohsen, Al-Zahrani
Publikováno v:
World Journal of Transplantation
AIM To examine the outcome and prognostic factors for high risk patients with acute lymphoblastic leukemia/lymphoma (ALL/LBL) who underwent allogeneic hematopoietic stem cell transplantation (HCT) at our center during the period of 2010-2017 METHODS
Autor:
Moussab, Damlaj, Ahmed, Alaskar, Samer, Ghazi, Bader, Alahmari, Ayman, Alhejazi, Mohsen, Al-Zahrani
Publikováno v:
Bone marrow transplantation. 53(10)